Page last updated: 2024-08-18

framycetin and Granuloma, Hodgkin

framycetin has been researched along with Granuloma, Hodgkin in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (33.33)	18.7374
1990's	1 (33.33)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aguilar, LK; Brenner, MK; Carrum, G; Gresik, MV; Grilley, B; Heslop, HE; Krance, RA; McClain, K; Rob, E; Rooney, CM; Roskrow, MA	1
Bollard, C; Brenner, M; Carrum, G; Gahn, B; Gee, A; Gresik, M; Grilley, B; Heslop, H; Khan, S; Krance, R; Kuehnle, I; Popat, U; Przepiorka, D; Rooney, C	1
Donner, L; Klener, P; Neuwirtová, R	1

Trials

2 trial(s) available for framycetin and Granuloma, Hodgkin

Article	Year
Administration of neomycin resistance gene marked EBV specific cytotoxic T-lymphocytes to patients with relapsed EBV-positive Hodgkin disease. Human gene therapy, 1998, May-20, Volume: 9, Issue:8 Topics: Anti-Bacterial Agents; Cell Line; Drug Resistance, Microbial; Feasibility Studies; Genes, Viral; Genetic Markers; Genetic Vectors; Herpesvirus 4, Human; Hodgkin Disease; Humans; Injections, Intravenous; Neomycin; Neoplasm Recurrence, Local; Retroviridae; T-Lymphocytes, Cytotoxic	1998
Administration of neomycin resistance gene-marked EBV-specific cytotoxic T-lymphocytes as therapy for patients receiving a bone marrow transplant for relapsed EBV-positive Hodgkin disease. Human gene therapy, 2000, Jul-01, Volume: 11, Issue:10 Topics: Bone Marrow Transplantation; Cell Line; Drug Resistance, Neoplasm; Feasibility Studies; Female; Genetic Therapy; Herpesvirus 4, Human; Hodgkin Disease; Humans; Male; Neomycin; Recurrence; T-Lymphocytes, Cytotoxic	2000

Article

Year

Administration of neomycin resistance gene marked EBV specific cytotoxic T-lymphocytes to patients with relapsed EBV-positive Hodgkin disease.

Human gene therapy, 1998, May-20, Volume: 9, Issue:8

Topics: Anti-Bacterial Agents; Cell Line; Drug Resistance, Microbial; Feasibility Studies; Genes, Viral; Genetic Markers; Genetic Vectors; Herpesvirus 4, Human; Hodgkin Disease; Humans; Injections, Intravenous; Neomycin; Neoplasm Recurrence, Local; Retroviridae; T-Lymphocytes, Cytotoxic

1998

Administration of neomycin resistance gene-marked EBV-specific cytotoxic T-lymphocytes as therapy for patients receiving a bone marrow transplant for relapsed EBV-positive Hodgkin disease.

Human gene therapy, 2000, Jul-01, Volume: 11, Issue:10

Topics: Bone Marrow Transplantation; Cell Line; Drug Resistance, Neoplasm; Feasibility Studies; Female; Genetic Therapy; Herpesvirus 4, Human; Hodgkin Disease; Humans; Male; Neomycin; Recurrence; T-Lymphocytes, Cytotoxic

2000

Other Studies

1 other study(ies) available for framycetin and Granuloma, Hodgkin

Article	Year
[Pimaricin therapy in mycotic complications of hemoblastosis]. Blut, 1972, Volume: 24, Issue:3 Topics: Adult; Aged; Antifungal Agents; Candidiasis; Drug Combinations; Female; Hodgkin Disease; Humans; Hydrocortisone; Leukemia; Lymphatic Diseases; Male; Middle Aged; Natamycin; Neomycin; Ointments; Stomatitis; Suppositories; Tablets; Time Factors; Vaginitis	1972